| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_715946dfd122eb9277028d69e0cf56a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8536caf3293906e1d2c229615e7d92bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_deb5fdd0a736b76c3f2b6b5cd097df0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bda3b94ea11085393d8f064a9f02fb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f43c7c3ae3f2e155a4a8bef08352e4f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_133c2226ea7af90e6c2e0eff0300d629 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4703 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate |
2009-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87ee1decf2182e7c776b0e953a6dd05d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c1ce4d5bad6169debfb2f365e743d55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2674e8b9c10e5855d90a24ce125f0d6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e812ed98570c8a415e51d8ba46f8bdb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07d5ea0fa020aa178e7186faedb31948 |
| publicationDate |
2010-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010006601-A1 |
| titleOfInvention |
Pax 5 monoclonal antibody |
| abstract |
The present invention relates to novel anti-human PAX 5 antibodies capable of binding to one or more epitopes located within the C-terminal regulatory domain of PAX 5. In particular the invention relates to an antibody, antigen binding fragment or recombinant protein thereof, which is capable of specific binding to an epitope located within the C-terminal fragment of human PAX 5 protein, wherein said epitope comprises from 3 to 17 amino acid residues of amino acid sequence GSPYYYSAAARGAAPPA (SEQ ID NO:2). The invention also relates to immunogenic peptide sequences for the production of the antibodies, diagnostic and therapeutic applications comprising using the antibodies and formulations comprising thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102643329-A |
| priorityDate |
2008-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |